SIMPLY SOLVENTLESS CNCTRT (SSLCF) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 30 59 sessions, September 10, 2025 to September 21, 2026
- Largest daily move
- +2400% close of August 5, 2026
- 1-year change
- -85.7% closing prices, September 10, 2025 to September 21, 2026
- 1-month change
- +0% closing prices, August 5, 2026 to September 21, 2026
Company Description
SIMPLY SOLVENTLESS CNCTRT (OTC: SSLCF) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $3.5M.
SSLCF has declined 85.7% over the past year. The last closing price was $0.0300.
This page collects what Stock Titan holds for SSLCF, including price data, latest news, and short interest trends.
Stock Performance
SIMPLY SOLVENTLESS CNCTRT (SSLCF) closed at $0.0300 on September 21, 2026. Over the past 12 months, the price has lost 85.7%.
SSLCF Metrics & Rankings
Price returns through September 21, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
SIMPLY SOLVENTLESS CNCTRT has 6 recent news articles. Of the recent coverage, 0 articles coincided with positive price movement and 2 with negative movement. Key topics include management. View all SSLCF news →
SEC Filings
Short Interest History
Short interest in SIMPLY SOLVENTLESS CNCTRT (SSLCF) currently stands at 8.8 thousand shares, representing 0.0% of the float. Since November 2025, short interest has decreased by 51.0%.
Days to Cover History
Days to cover for SIMPLY SOLVENTLESS CNCTRT (SSLCF) currently stands at 52.8 days, up 1098% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since November 2025, the figure has increased by 5183%. Across the settlements charted above, it has ranged from 1.0 to 1000.0 days.
SSLCF Company Profile & Sector Positioning
SIMPLY SOLVENTLESS CNCTRT (SSLCF) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC.